ATXI - Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32
2023-11-14 01:52:35 ET
More on Avenue Therapeutics
- Avenue Therapeutics stock plummets on pricing of 16.6M units at $0.3006 in public offering
- Avenue Therapeutics drops 6% on proposed equity offering
- Seeking Alpha’s Quant Rating on Avenue Therapeutics
- Historical earnings data for Avenue Therapeutics
- Financial information for Avenue Therapeutics
For further details see:
Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32